Lisa Schnirring | News Editor | CIDRAP NewsOct 08, 2020As Regeneron becomes the second firm to apply for an EUA for an experimental antibody treatment, experts call for approvals to be based on rigorous science.
COVID-19 rattles US election lead-up as global total tops 36 million
More from COVID-19More posts in COVID-19 »